In a dengue patient with a spontaneous subdural hematoma, is fresh frozen plasma indicated and what coagulation abnormalities would warrant its use?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

FFP in Spontaneous Subdural Hematoma in Dengue Patients

Fresh frozen plasma is NOT routinely indicated for spontaneous subdural hematoma in dengue patients unless there is documented coagulopathy with INR >1.5 or specific coagulation factor deficiencies, and even then, platelet transfusion and surgical evacuation take priority over FFP. 1

Primary Management Approach

Platelet transfusion is the critical intervention for dengue-related intracranial hemorrhage, not FFP. 2 The pathophysiology of bleeding in dengue is primarily thrombocytopenia-driven, not coagulation factor deficiency. 2, 3

When FFP May Be Considered

FFP should only be administered if ALL of the following criteria are met:

  • Active bleeding is present (expanding hematoma or clinical deterioration) 1, 4
  • Documented coagulopathy with INR ≥1.5, PT >1.5 times normal, or aPTT >2 times normal 1, 5
  • Patient is being prepared for urgent neurosurgical evacuation 1, 4

Specific Dosing if FFP is Indicated

If the above criteria are met, administer 10-15 ml/kg (approximately 700-1050 ml for a 70 kg patient, or 3-4 units) as rapidly as clinically tolerated. 5, 6 Doses below 10 ml/kg are unlikely to achieve the 30% factor concentration threshold needed for hemostasis. 5

Critical Coagulation Parameters to Check

Before considering FFP, obtain:

  • Platelet count (primary concern in dengue; transfuse if <50,000/mm³ with active bleeding or <10,000/mm³ prophylactically) 2
  • INR/PT and aPTT (FFP only justified if INR >1.5) 1
  • Fibrinogen level (if <1.5 g/L, use cryoprecipitate instead of FFP) 1, 5
  • Liver enzymes (AST/ALT) (elevated levels are risk factors for bleeding in dengue) 2

Common Pitfalls to Avoid

Do not use FFP to correct laboratory values alone without active bleeding. 1, 5 This is a critical error that exposes patients to unnecessary risks including TRALI, circulatory overload, and infectious transmission. 5

Do not use FFP as a treatment for thrombocytopenia in dengue. 3 While one study showed a transient platelet increase at 12 hours post-FFP infusion, this effect was not sustained at 24-48 hours and is not clinically meaningful. 3 The mechanism of thrombocytopenia in dengue is consumptive and immune-mediated, not factor deficiency. 2

Do not delay neurosurgical consultation while attempting medical reversal. 2 Dengue-related subdural hematomas often require urgent surgical evacuation regardless of coagulation status. 2, 7

Evidence-Based Management Algorithm

  1. Confirm diagnosis: Dengue serology (IgG/IgM, NS1 antigen) plus neuroimaging showing subdural hematoma 2, 7

  2. Assess bleeding severity: Serial CT scans to evaluate hematoma progression 2, 8

  3. Check coagulation profile: Platelet count, INR, PT, aPTT, fibrinogen 2

  4. Primary interventions:

    • Platelet transfusion if count <50,000/mm³ with active bleeding 2
    • Urgent neurosurgical evaluation for evacuation 2, 7
    • FFP only if INR >1.5 at dose of 10-15 ml/kg 1, 5
  5. Monitor: Repeat imaging and coagulation studies every 3-6 hours initially 8

Special Considerations for Dengue

Unlike anticoagulant-associated intracranial hemorrhage where FFP has clear indications 1, dengue-related hemorrhage is fundamentally different. The coagulation profile in dengue patients is often normal or only mildly deranged despite severe thrombocytopenia. 2, 7 One case report documented a dengue patient with spontaneous spinal subdural hematoma whose "hemogram, biochemistry, and coagulation profile was within normal limits." 7

Risk factors for bleeding in dengue include: thrombocytopenia, elevated AST/ALT, and positive IgG antibodies (indicating secondary infection). 2 These do not respond to FFP therapy.

Administration Details if FFP is Used

  • ABO compatibility required: Use group AB if blood type unknown 5, 9
  • Infusion rate: As rapidly as tolerated in acute bleeding 5
  • Monitoring: Recheck INR 15-60 minutes post-infusion 1
  • Storage: Once thawed, use within 30 minutes if removed from refrigeration 5, 9

Related Questions

What is the next step in managing a 6-year-old female patient with suspected dengue fever, presenting with fever, cough, cold, petechial spots, leukopenia, thrombocytopenia, and mild hepatomegaly?
A 60-year-old man with chronic hepatitis C and cirrhosis presents with a perforated peptic ulcer requiring urgent laparotomy; labs show hemoglobin 90 g/L, platelet count 90 ×10⁹/L, international normalized ratio 2, prothrombin time 17 seconds. What is the most appropriate next step in management before surgery: platelets, cryoprecipitate, fresh frozen plasma, or packed red blood cells?
What is the most appropriate management for a patient on warfarin (anticoagulant) with a subdural hematoma and elevated International Normalized Ratio (INR)?
Is Fresh Frozen Plasma (FFP) necessary for a patient with adenocarcinoma of the rectum and liver metastases?
What is the most appropriate next step in management for a patient with a subdural hematoma, elevated International Normalized Ratio (INR) due to warfarin (anticoagulant) therapy, who has already received vitamin K (phytonadione)?
What is the recommended management of cutaneous leishmaniasis in an immunocompetent adult with up to five lesions each ≤5 cm in diameter?
What are the diagnostic criteria for undifferentiated connective tissue disease (UCTD)?
For a healthy adult with a platelet count above 50 × 10⁹/L who needs an atraumatic lumbar puncture, how long should direct oral anticoagulants be stopped before the procedure, taking into account normal versus impaired renal function?
Can a urine culture and antimicrobial susceptibility test be performed while the patient is currently taking nitrofurantoin?
Does vancomycin provide adequate coverage for methicillin‑susceptible Staphylococcus aureus (MSSA) infections in adults?
What are the risk factors for amyotrophic lateral sclerosis (ALS)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.